» Articles » PMID: 36713455

CRISPR Interference for Sequence-specific Regulation of Fibroblast Growth Factor Receptor A in

Overview
Journal Front Immunol
Date 2023 Jan 30
PMID 36713455
Authors
Affiliations
Soon will be listed here.
Abstract

Employing the flatworm parasite as a model, we report the first application of CRISPR interference (CRISPRi) in parasitic helminths for loss-of-function studies targeting the gene which encodes the stem cell marker, fibroblast growth factor receptor A (FGFRA). SmFGFRA is essential for maintaining schistosome stem cells and critical in the schistosome-host interplay. The gene was targeted in adult worms, eggs and schistosomula using a catalytically dead Cas9 (dCas9) fused to a transcriptional repressor KRAB. We showed that repression resulted in considerable phenotypic differences in the modulated parasites compared with controls, including reduced levels of transcription and decreased protein expression of SmFGFRA, a decline in EdU (thymidine analog 5-ethynyl-2'-deoxyuridine, which specifically stains schistosome stem cells) signal, and an increase in cell apoptosis. Notably, reduced transcription was evident in miracidia hatched from -repressed eggs, and resulted in a significant change in miracidial behavior, indicative of a durable repression effect caused by CRISPRi. Intravenous injection of mice with -repressed eggs resulted in granulomas that were markedly reduced in size and a decline in the level of serum IgE, emphasizing the importance of SmFGFRA in regulating the host immune response induced during schistosome infection. Our findings show the feasibility of applying CRISPRi for effective, targeted transcriptional repression in schistosomes, and provide the basis for employing CRISPRi to selectively perturb gene expression in parasitic helminths on a genome-wide scale.

Citing Articles

The retinoic acid family-like nuclear receptor SmRAR identified by single-cell transcriptomics of ovarian cells controls oocyte differentiation in Schistosoma mansoni.

Moescheid M, Lu Z, Soria C, Quack T, Puckelwaldt O, Holroyd N Nucleic Acids Res. 2024; 53(4).

PMID: 39676663 PMC: 11879061. DOI: 10.1093/nar/gkae1228.


CRISPR-based functional genomics for schistosomes and related flatworms.

Ittiprasert W, Brindley P Trends Parasitol. 2024; 40(11):1016-1028.

PMID: 39426911 PMC: 11560492. DOI: 10.1016/j.pt.2024.09.010.


Transmission-Blocking Vaccines against Schistosomiasis Japonica.

Zumuk C, Jones M, Navarro S, Gray D, You H Int J Mol Sci. 2024; 25(3).

PMID: 38338980 PMC: 10855202. DOI: 10.3390/ijms25031707.


Targeted insertion and reporter transgene activity at a gene safe harbor of the human blood fluke, .

Ittiprasert W, Moescheid M, Chaparro C, Mann V, Quack T, Rodpai R Cell Rep Methods. 2023; 3(7):100535.

PMID: 37533651 PMC: 10391569. DOI: 10.1016/j.crmeth.2023.100535.

References
1.
Gratz S, Cummings A, Nguyen J, Hamm D, Donohue L, Harrison M . Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics. 2013; 194(4):1029-35. PMC: 3730909. DOI: 10.1534/genetics.113.152710. View

2.
Rinaldi G, Eckert S, Tsai I, Suttiprapa S, Kines K, Tort J . Germline transgenesis and insertional mutagenesis in Schistosoma mansoni mediated by murine leukemia virus. PLoS Pathog. 2012; 8(7):e1002820. PMC: 3406096. DOI: 10.1371/journal.ppat.1002820. View

3.
Sarig R, Rotter V . Can an iPS cell secure its genomic fidelity?. Cell Death Differ. 2011; 18(5):743-4. PMC: 3131921. DOI: 10.1038/cdd.2011.14. View

4.
Markus B, Boydston E, Lourido S . CRISPR-Mediated Transcriptional Repression in Toxoplasma gondii. mSphere. 2021; 6(5):e0047421. PMC: 8513686. DOI: 10.1128/mSphere.00474-21. View

5.
Hahnel S, Quack T, Parker-Manuel S, Lu Z, Vanderstraete M, Morel M . Gonad RNA-specific qRT-PCR analyses identify genes with potential functions in schistosome reproduction such as SmFz1 and SmFGFRs. Front Genet. 2014; 5:170. PMC: 4050651. DOI: 10.3389/fgene.2014.00170. View